Ondansetron and Dermatomyositis - a phase IV clinical study of FDA data

Summary:

Dermatomyositis is reported as a side effect among people who take Ondansetron (ondansetron), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Taxol, and have Breast cancer.

The phase IV clinical study analyzes which people have Dermatomyositis when taking Ondansetron. It is created by eHealthMe based on reports of 122,217 people who have side effects when taking Ondansetron from the FDA, and is updated regularly.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

What is Dermatomyositis?

Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer) is found to be associated with 263 drugs and 415 conditions by eHealthMe. Check the latest studies of Dermatomyositis.

On Jul, 18, 2026

122,217 people reported to have side effects when taking Ondansetron.
Among them, 16 people (0.01%) have Dermatomyositis.

Could Ondansetron cause Dermatomyositis?

Among these 16 people:

How long have people been on Ondansetron when they have Dermatomyositis? *

What is the gender of people who have Dermatomyositis when taking Ondansetron? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Dermatomyositis when taking Ondansetron? *

What are other drugs people take besides Ondansetron? *

Carboplatin: 6 people, 37.50%
Taxol: 6 people, 37.50%
Vitamin D3: 5 people, 31.25%
Zofran: 3 people, 18.75%
Hydroxyzine Hydrochloride: 3 people, 18.75%
Nifedipine: 3 people, 18.75%
Neurontin: 3 people, 18.75%
Naltrexone Hydrochloride: 3 people, 18.75%
Magnesium: 3 people, 18.75%
Lexapro: 3 people, 18.75%

What are other side effects people have besides Dermatomyositis? *

Face Oedema (swelling of face): 6 people, 37.50%
Muscle Aches (muscle pain): 3 people, 18.75%
Menopause (end of monthly cycles in women): 3 people, 18.75%
Fall: 3 people, 18.75%
Fever: 3 people, 18.75%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 3 people, 18.75%
Head Injury: 3 people, 18.75%
Headache (pain in head): 3 people, 18.75%
Herpes Zoster: 3 people, 18.75%
Chest Pain: 3 people, 18.75%

What are the existing conditions these people have? *

Myopathy (a muscular disease in which the muscle fibres do not function): 3 people, 18.75%
Breast Cancer Metastatic: 3 people, 18.75%
Breast Cancer: 3 people, 18.75%
Ovarian Cancer (cancer of ovary): 2 people, 12.50%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 1 person, 6.25%
Lung Cancer - Small Cell (lung cancer): 1 person, 6.25%
Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)): 1 person, 6.25%
Cough: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and have Dermatomyositis?

- Check whether Dermatomyositis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ondansetron:

Ondansetron (122,738 reports)

Dermatomyositis treatments and more:

Dermatomyositis (8,399 reports)

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatomyositis:

Dermatomyositis (263 drugs)

Browse all the conditions that are associated with Dermatomyositis:

Dermatomyositis (415 conditions)

Related publications that referenced our studies

Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ondansetron (the active ingredients of Ondansetron) and Ondansetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.